Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy [NA]

View source ↗

Summary

This clinical trial is evaluating whether a late-evening and early-morning protein supplement can reduce readmissions in patients with hepatic encephalopathy. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Late-evening and early-morning protein supplement

Snippet

Sponsor: The Cleveland Clinic | Conditions: Hepatic Encephalopathy | NA | Status: RECRUITING